Evidence map›Paper›PMID 24560519›Full record

ArticleAmerican journal of human genetics2014

Exome-based mapping and variant prioritization for inherited Mendelian disorders.

Daniel C Koboldt, David E Larson, Lori S Sullivan, Sara J Bowne, Karyn M Steinberg, Jennifer D Churchill, Aimee C Buhr, Nathan Nutter, Eric A Pierce, Susan H Blanton and 3 more

Open access · bronzeAbstract read
In one paragraph

Article in American journal of human genetics, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
4.0field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 40 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Identification of Rare Variants Predisposing to Thyroid Cancer.Thyroid : official journal of the American Thyroid Association · 2019
    Article
  7. Article
  8. Article
  9. Article
  10. Assigning clinical meaning to somatic and germ-line whole-exome sequencing data in a prospective cancer precision medicine study.Genetics in medicine : official journal of the American College of Medical Genetics · 2017
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 4 institutions in 1 country.

Daniel C KoboldtThe Genome Institute at Washington University, St. Louis, MO 63108, USA. Electronic address: dkoboldt@genome.wustl.edu.
David E LarsonThe Genome Institute at Washington University, St. Louis, MO 63108, USA.
Lori S SullivanHuman Genetics Center, University of Texas Health Science Center, Houston, TX 77025, USA.
Sara J BowneHuman Genetics Center, University of Texas Health Science Center, Houston, TX 77025, USA.
Karyn M SteinbergThe Genome Institute at Washington University, St. Louis, MO 63108, USA.
Jennifer D ChurchillHuman Genetics Center, University of Texas Health Science Center, Houston, TX 77025, USA.
Aimee C BuhrHuman Genetics Center, University of Texas Health Science Center, Houston, TX 77025, USA.
Nathan NutterThe Genome Institute at Washington University, St. Louis, MO 63108, USA.
Eric A PierceOcular Genomics Institute, Harvard Medical School, Boston, MA 02114, USA.
Susan H BlantonHussman Institute of Human Genomics, University of Miami, Miami, FL 33101, USA.
George M WeinstockThe Genome Institute at Washington University, St. Louis, MO 63108, USA.
Richard K WilsonThe Genome Institute at Washington University, St. Louis, MO 63108, USA.
Stephen P DaigerHuman Genetics Center, University of Texas Health Science Center, Houston, TX 77025, USA. Electronic address: stephen.p.daiger@uth.tmc.edu.
Washington University in St. Louis · USThe University of Texas Health Science Center at Houston · USHarvard University · USUniversity of Miami · US

Funding

Large Scale Genome SequencingU54HG003079 · NHGRI · WASHINGTON UNIVERSITY · PI DUTCHER, SUSAN K · 2004 to 2016
$445.7M
Precision Medicine for Inherited Retinal DegenerationsR01EY012910 · NEI · UNIVERSITY OF PENNSYLVANIA · PI Eric A Pierce · 1999 to 2026
$15.9M
DNA LINKAGE STUDIES OF DEGENERATIVE RETINAL DISEASESR01EY007142 · NEI · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI DAIGER, STEPHEN P · 1989 to 2017
$4.1M
NEI NIH HHS EY007142NEI NIH HHS R01 EY007142NEI NIH HHS R01 EY012910NHGRI NIH HHS HG003079NHGRI NIH HHS U54 HG003079
6 · The paper itself

Abstract

Exome sequencing in families affected by rare genetic disorders has the potential to rapidly identify new disease genes (genes in which mutations cause disease), but the identification of a single causal mutation among thousands of variants remains a significant challenge. We developed a scoring algorithm to prioritize potential causal variants within a family according to segregation with the phenotype, population frequency, predicted effect, and gene expression in the tissue(s) of interest. To narrow the search space in families with multiple affected individuals, we also developed two complementary approaches to exome-based mapping of autosomal-dominant disorders. One approach identifies segments of maximum identity by descent among affected individuals; the other nominates regions on the basis of shared rare variants and the absence of homozygous differences between affected individuals. We showcase our methods by using exome sequence data from families affected by autosomal-dominant retinitis pigmentosa (adRP), a rare disorder characterized by night blindness and progressive vision loss. We performed exome capture and sequencing on 91 samples representing 24 families affected by probable adRP but lacking common disease-causing mutations. Eight of 24 families (33%) were revealed to harbor high-scoring, most likely pathogenic (by clinical assessment) mutations affecting known RP genes. Analysis of the remaining 17 families identified candidate variants in a number of interesting genes, some of which have withstood further segregation testing in extended pedigrees. To empower the search for Mendelian-disease genes in family-based sequencing studies, we implemented them in a cross-platform-compatible software package, MendelScan, which is freely available to the research community.

Indexed as

ExomeChromosome MappingCohort StudiesComputational BiologyDatabases, GeneticFemaleGene Expression ProfilingGene Expression RegulationGenes, DominantGenetic LinkageGenetic MarkersGenetic VariationGenotypeHeterozygoteHumansMaleGenetic Markers

Identifiers

PMID24560519
PMCPMC3951946
OpenAlexW2094181083

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.